Clinical trial
Evaluation of Heysong Japanese Green Tea for Improving Blood Lipid Function
NCT06992765 is registered in ClinicalTrials.gov with Taipei Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Heysong Japanese Green Tea for Improving Blood Lipid Function
- Lead sponsor
- Taipei Medical University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 15, 2023
- Completion date
- August 30, 2025
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.